In the second segment of "Foodie or Food Noise", Dr. Catherine Toomer shares her personal journey with type 2 diabetes, heart failure, and obesity, and how GLP1s played a crucial role in saving her life. As a physician, Dr. Toomer sheds light on the scarcity of these medications and stresses the significance of having access to compound pharmacy options. She also highlights the fact that several states have prohibited the compounding of GLP1s such as Semaglutide and Tirzepatide, which are active ingredients found in popular medications like Ozempic and Mounjaro. Dr. Toomer provides insights on how to select a reliable compound pharmacy and identifies potential warning signs to watch out for.Support the showKim Carlos @DMFKimonMounjaro on TikTokJernine Trott @TheeJernine on TikTokKat Carter @KatCarter7 on TikTokLydia Roberts @mounjaro_GLP_Help on TikTok